Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Cmed has announced it will present its encapsia clinical data suite at Mobile in Clinical Trials and DPharm: Disruptive Innovations to Advance Clinical Trials 2017.
read more
Spray drying and capsule filling service provider Micro-Sphere is investing €19 million into expanding its GMP manufacturing capabilities at its facility in Switzerland.
read more
Dr. Reddy’s Laboratories has out-licensed the future development, manufacturing, and commercialization rights of DFD-06, a topical high potency steroid, to Encore Dermatology.
read more
Crown Bioscience announced the appointment of Dr. Leon Hall as Vice President of Global Scientific Excellence.
read more
Wednesday, August 23, 2017
ChromaDex has signed a definitive agreement to sell its analytical testing services business to LabCorp.
read more
Wednesday, August 23, 2017
GNS Healthcare has raised an additional $6 million in equity from Amgen Ventures with participation from existing investor Alexandria Real Estate Equities.
read more
Wednesday, August 23, 2017
Caret Pharma has entered into an agreement with Moberg Pharma AB to acquire the assets of Fiber Choice, a line of dietary supplements containing 100% natural, prebiotic fiber.
read more
Wednesday, August 23, 2017
SillaJen has entered into a CRADA with the National Cancer Institute for the development of a combination therapy for colorectal cancer.
read more
Wednesday, August 23, 2017
Trial By Fire Solutions has released SimpleTrials 2.0, a clinical trial management system (CTMS) with new features such as site contracts and payments management.
read more
Wednesday, August 23, 2017
WuXi Biologics announces its unaudited interim results for the six months ended June 30, 2017.
read more
Thursday, August 24, 2017
Ajinomoto Althea, Inc. (“Althea”), a leading service provider of biopharmaceutical contract development and manufacturing drug programs, announces the installation and launch of a new high-performance sterile vial filling line.
read more
CordenPharma Latina has received news that the US-FDA warning letter previously received has been closed, with a closeout date of August 15, 2017.
read more
Eurofins Pharma Bioanalytical Services announced it will extend its laboratory services to provide consulting to clients to who require expertise and experience in conducting large molecule preclinical and clinical studies.
read more
Daiichi Sankyo Company and Boston Pharmaceuticals, Inc. have entered into a worldwide licensing agreement for Daiichi Sankyo's novel RET inhibitor, DS-5010.
read more
Lumosa Therapeutics Co., a Taipei-based biopharmaceutical company developing innovative therapies focused on the treatment of neurological and inflammatory disease, has announced that the FDA has confirmed the 505(b)(2) regulatory pathway is ...
read more